Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Sep;11 Suppl 4(Suppl 4):s45-54.
doi: 10.2450/2013.009s.

The demand for polyvalent immunoglobulins in Italy

Fabio Candura  1 , Monica Lanzoni  2 , Gabriele Calizzani  1 , Samantha Profili  1 , Stefania Vaglio  3 , Simonetta Pupella  1 , Giancarlo M Liumbruno  4 , Giuliano Grazzini  1
Affiliations
Review

The demand for polyvalent immunoglobulins in Italy

Fabio Candura et al. Blood Transfus. 2013 Sep.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Quantification of total (public and private) standardised demand for polyvalent immunoglobulins for subcutaneous and for intravascular administration, expressed in grams per 1,000 population, in Italy and Italian Regions in 2011. Source: medicinal product traceability, processed and adapted by the Italian National Blood Centre.
Figure 2
Figure 2
Percentage change from the national mean value of regional standardised demand for polyvalent immunoglobulins for subcutaneous and intravenous administration. Source: medicinal product traceability, processed and adapted by the Italian National Blood Centre.
Figure 3
Figure 3
Quantification of total (public and private) standardised demand for polyvalent immunoglobulins for subcutaneous administration (grams per 1,000 population), in Italy and Italian Regions in 2011. Source: medicinal product traceability, processed and adapted by the Italian National Blood Centre.
Figure 4
Figure 4
Percentage change from the national mean value of regional standardised demand for immunoglobulins for subcutaneous administration in 2011. Source: medicinal product traceability, processed and adapted by the Italian National Blood Centre.
Figure 5
Figure 5
Quantification of total (public and private) standardised demand (grams per 1,000 population) for polyvalent immunoglobulins for intravenous administration in Italy and Italian regions in 2011. Source: medicinal product traceability, processed and adapted by the Italian National Blood Centre.
Figure 6
Figure 6
Percentage change from the national mean value of regional standardised demand for immunoglobulins for intravenous administration in 2011. Source: medicinal product traceability, processed and adapted by the Italian National Blood Centre.
Figure 7
Figure 7
Demand for polyvalent immunoglobulins for subcutaneous and intravascular administration (grams per 1,000 population) in some European and extra-European Countries. Source for Italy (2011): medicinal product traceability, processed and adapted by the Italian National Blood Centre; source for European and extra-European Countries (2010): Robert P, 2010.
See this image and copyright information in PMC

References

    1. Liumbruno GM, Bennardello F, Lattanzio A, et al. Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) Working Party. Recommendations for the use of albumin and immunoglobulins. Blood Transfus. 2009;7(Suppl 3):216–34. - PMC - PubMed
    1. Knezevic-Maramica I, Kruskall MS. Intravenous immune globulins: an update for clinicians. Transfusion. 2003;43:1460–80. - PubMed
    1. Looney RJ, Huggins J. Use of intravenous immunoglobulin G (IVIG) Best Pract Res Clin Haematol. 2006;19:3–25. - PubMed
    1. Quinti I, Coluzzi S, Pulvirenti F, et al. Polyvalent immunoglobulins: challenges and perspectives. Blood Transfus. 2013;11(Suppl 4):s40–4. - PMC - PubMed
    1. Burnouf T. Modern plasma fractionation. Transfus Med Rev. 2007;21:101–17. - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources